8-KOther EventsExhibits & Filings

UNITEDHEALTH GROUP INC 8-K Report, Corporate Update (Mar 13, 2017)

Filed March 13, 2017For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) filed an 8-K on March 13, 2017, to report on the issuance of new debt securities. The company successfully sold $625 million in 3.375% Notes due April 15, 2027, and $725 million in 4.250% Notes due April 15, 2047. This debt issuance, totaling $1.35 billion, was facilitated through an Underwriting Agreement and Pricing Agreement with J.P. Morgan Securities LLC, Goldman, Sachs & Co., Merrill Lynch, Pierce, Fenner & Smith Incorporated, and Morgan Stanley & Co. LLC, acting as representatives for the underwriters. These notes were issued under the company's existing shelf registration statement. Investors should view this as a routine financing activity by UnitedHealth Group to manage its capital structure and potentially fund ongoing operations, acquisitions, or other corporate initiatives. The specific use of proceeds is not detailed in this filing, but the issuance indicates a need for significant capital, likely to support the company's substantial growth and market position in the healthcare industry.

Key Highlights

  • 1UnitedHealth Group issued $625 million in 3.375% Notes due 2027 and $725 million in 4.250% Notes due 2047.
  • 2Total aggregate principal amount of new debt issued is $1.35 billion.
  • 3The debt issuance occurred on March 13, 2017.
  • 4Key financial institutions, including J.P. Morgan, Goldman Sachs, Merrill Lynch, and Morgan Stanley, acted as underwriters.
  • 5The notes were registered under the company's Form S-3 shelf registration statement.
  • 6This filing confirms standard corporate financing activities to manage capital structure.

Frequently Asked Questions

This 8-K filing reports on the successful issuance of new long-term debt securities by UnitedHealth Group. It details the principal amounts, interest rates, and maturity dates of the notes, as well as the parties involved in the underwriting process.

UnitedHealth Group raised a total of $1.35 billion by issuing $625 million of 3.375% Notes due April 15, 2027, and $725 million of 4.250% Notes due April 15, 2047. The specific cost of this debt is reflected in the stated coupon rates of 3.375% and 4.250%.

The 8-K filing itself does not specify the exact use of the proceeds from this debt issuance. However, such financings are typically used for general corporate purposes, which can include funding operations, capital expenditures, potential acquisitions, refinancing existing debt, or returning capital to shareholders.

The debt offering was managed by J.P. Morgan Securities LLC, Goldman, Sachs & Co., Merrill Lynch, Pierce, Fenner & Smith Incorporated, and Morgan Stanley & Co. LLC, who acted as representatives for the several underwriters.